Anti-mGlu2 blocking peptide

Discontinued Product

Anti-mGlu2 blocking peptide (Cat. No. 2100) has been withdrawn from sale for commercial reasons.
Description: Blocking peptide for anti-mGlu2 (Cat. No. 2027)
Literature (5)

Biological Activity for Anti-mGlu2 blocking peptide

Synthetic peptide ([C]-RAPTSRFGSAAPRASAN) corresponding to amino acids 829-845 of rat precursor mGlu2 (Accession No. P31421) with a cysteine added at the N-terminus of the peptide. Used as an immunogen for anti-mGlu2 (Cat. No. 2027).

Technical Data for Anti-mGlu2 blocking peptide

M. Wt 1819.03
Formula C74H123N29O23S

(Modifications: Asn-18 = C-terminal amide)

Storage Desiccate at -20°C
Smiles [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for Anti-mGlu2 blocking peptide

Certificate of Analysis is currently unavailable on-line.
Please contact Customer Service

References for Anti-mGlu2 blocking peptide

References are publications that support the biological activity of the product.

Keywords: Anti-mGlu2 blocking peptide, Anti-mGlu2 blocking peptide supplier, Blocking, peptides, anti-mGlu2, mGluR2, Group, II, Receptors, Glutamate, Metabotropic, immunogen, (Metabotropic), 2100, Tocris Bioscience

Citations for Anti-mGlu2 blocking peptide

Citations are publications that use Tocris products.

Currently there are no citations for Anti-mGlu2 blocking peptide.

Reviews for Anti-mGlu2 blocking peptide

There are currently no reviews for this product. Be the first to review Anti-mGlu2 blocking peptide and earn rewards!

Have you used Anti-mGlu2 blocking peptide?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.

Metabotropic Glutamate Receptors Scientific Review

Metabotropic Glutamate Receptors Scientific Review

Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.

Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Learning & Memory Poster

Learning & Memory Poster

Recognition memory enables us to make judgements about whether or not we have encountered a particular stimulus before. This poster outlines the cellular mechanisms underlying recognition memory and its links to long-term depression, as well as the use of pharmacological intervention to assess the role of neurotransmitters in recognition memory.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.